Sökning: WFRF:(Tanton Clare) > Population-level ef...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03694naa a2200541 4500 | |
001 | oai:lup.lub.lu.se:3c209bcf-8f1c-44e3-90dc-0bd9d919972e | |
003 | SwePub | |
008 | 161019s2016 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/3c209bcf-8f1c-44e3-90dc-0bd9d919972e2 URI |
024 | 7 | a https://doi.org/10.3201/eid2210.1606752 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Mesher, Davidu Public Health England4 aut |
245 | 1 0 | a Population-level effects of human papillomavirus vaccination programs on infections with nonvaccine genotypes |
264 | 1 | b Centers for Disease Control and Prevention (CDC),c 2016 |
300 | a 9 s. | |
520 | a We analyzed human papillomavirus (HPV) prevalences during prevaccination and postvaccination periods to consider possible changes in nonvaccine HPV genotypes after introduction of vaccines that confer protection against 2 high-risk types, HPV16 and HPV18. Our meta-analysis included 9 studies with data for 13,886 girls and women ≤19 years of age and 23,340 women 20–24 years of age. We found evidence of cross-protection for HPV31 among the younger age group after vaccine introduction but little evidence for reductions of HPV33 and HPV45. For the group this same age group, we also found slight increases in 2 nonvaccine high-risk HPV types (HPV39 and HPV52) and in 2 possible high-risk types (HPV53 and HPV73). However, results between age groups and vaccines used were inconsistent, and the increases had possible alternative explanations; consequently, these data provided no clear evidence for type replacement. Continued monitoring of these HPV genotypes is important. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Mikrobiologi inom det medicinska området0 (SwePub)301092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Microbiology in the medical area0 (SwePub)301092 hsv//eng |
700 | 1 | a Soldan, Kateu Public Health England4 aut |
700 | 1 | a Lehtinen, Mattiu University of Tampere4 aut |
700 | 1 | a Beddows, Simonu Public Health England4 aut |
700 | 1 | a Brisson, Marcu Imperial College London4 aut |
700 | 1 | a Brotherton, Julia M Lu University of Melbourne4 aut |
700 | 1 | a Chow, Eric P Fu Monash University4 aut |
700 | 1 | a Cummings, Teresau Indiana University4 aut |
700 | 1 | a Drolet, Mélanieu Laval University4 aut |
700 | 1 | a Fairley, Christopher K.u Monash University4 aut |
700 | 1 | a Garland, Suzanne M.4 aut |
700 | 1 | a Kahn, Jessica A.4 aut |
700 | 1 | a Kavanagh, Kimberley4 aut |
700 | 1 | a Markowitz, Lauri4 aut |
700 | 1 | a Pollock, Kevin G.u Health Protection Scotland4 aut |
700 | 1 | a Söderlund-Strand, Annau Lund University,Lunds universitet,Institutionen för laboratoriemedicin,Medicinska fakulteten,Department of Laboratory Medicine,Faculty of Medicine4 aut0 (Swepub:lu)mikr-aso |
700 | 1 | a Sonnenberg, Pam4 aut |
700 | 1 | a Tabrizi, Sepehr N.4 aut |
700 | 1 | a Tanton, Clare4 aut |
700 | 1 | a Unger, Elizabeth4 aut |
700 | 1 | a Thomas, Sara L.4 aut |
710 | 2 | a Public Health Englandb University of Tampere4 org |
773 | 0 | t Emerging Infectious Diseasesd : Centers for Disease Control and Prevention (CDC)g 22:10, s. 1732-1740q 22:10<1732-1740x 1080-6040x 1080-6059 |
856 | 4 | u http://dx.doi.org/10.3201/eid2210.160675x freey FULLTEXT |
856 | 4 | u https://wwwnc.cdc.gov/eid/article/22/10/pdfs/16-0675.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/3c209bcf-8f1c-44e3-90dc-0bd9d919972e |
856 | 4 8 | u https://doi.org/10.3201/eid2210.160675 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy